We are live on ! Find out more

58 hedge funds and large institutions have $3.76M invested in PAVmed in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,140% more call options, than puts

Call options by funds: $62K | Put options by funds: $5K

89% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 9

0% less ownership

Funds ownership: 0.02%0.02% (-0%)

6% less funds holding

Funds holding: 6258 (-4)

19% less capital invested

Capital invested by funds: $4.62M → $3.76M (-$869K)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
58
Holders Change
-4
Holders Change %
-6.45%
% of All Funds
0.92%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
17
Reduced
9
Closed
9
Calls
$62K
Puts
$5K
Net Calls
+$57K
Net Calls Change
-$56K

PAVM Hedge Fund Activity: Q1 2023 in Review

58 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q1 2023, worth a combined $3.76M — down 19% from $4.62M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of PAVM and 5 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 17 added.

The largest buyer was Ayrton Capital, opening a new position worth an estimated $201K. The largest seller was BlackRock, cutting an estimated $57K.

  • 58 institutional investors held PAVmed (PAVM) as of Q1 2023, down from 62 in Q4 2022.
  • Funds reported $3.76M of PAVmed stock for Q1 2023, down 19% quarter-over-quarter.
  • 5 funds opened new PAVmed positions in Q1 2023 and 9 closed out, a net change of -4 holders.
  • The largest PAVmed buyer in Q1 2023 was Ayrton Capital, an estimated $201K added.
  • The largest PAVmed seller in Q1 2023 was BlackRock, an estimated $57K sold.

Based on aggregated 13F filings for Q1 2023.